Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Toward a Human Vaccines Project

Nature Immunology volume 15, pages 589–592 (2014)Cite this article

Subjects

Technological advances in antigen discovery, genomics and immunological monitoring offer tremendous potential for revolutionizing vaccine development. On 5–6 February 2014, 35 leading vaccine scientists met to consider how best to harness these advances and spur innovation.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

O. Shmaidenko

Figure 2: The Human Vaccines Project.

References

  1. Centers for Disease Control and Prevention. MMWR Morb. Mortal. Wkly. Rep. 48, 621–629 (1999).

  2. US Food and Drug Administration. Vaccines, Blood & Biologics. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM093833 (2013).

  3. Nabel, G.J. N. Engl. J. Med. 368, 551–560 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Wendelboe, A.M., Van Rie, A., Salmaso, S. & Englund, J.A. Pediatr. Infect. Dis. J. 24, S58–S61 (2005).

    Article  PubMed  Google Scholar 

  5. Anderson, L.J. et al. Vaccine 31, B209–B215 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Lang, P.O. et al. Curr. Top. Med. Chem. 13, 2541–2550 (2013).

    Article  CAS  PubMed  Google Scholar 

  7. Wood, N. & Siegrist, C.A. Curr. Opin. Infect. Dis. 24, 190–195 (2011).

    Article  PubMed  Google Scholar 

  8. Chan, J. et al. Vaccine 29, 1242–1247 (2011).

    Article  CAS  PubMed  Google Scholar 

  9. Greenwood, B.M. & Targett, G.A. Clin. Microbiol. Infect. 17, 1600–1607 (2011).

    Article  CAS  PubMed  Google Scholar 

  10. Marinova, D., Gonzalo-Asensio, J., Aguilo, N. & Martin, C. Expert Rev. Vaccines 12, 1431–1448 (2013).

    Article  CAS  PubMed  Google Scholar 

  11. Wenxue, M. Curr. Med. Chem. (5 February 2014).

  12. Koff, W.C. et al. Science 340, 1232910 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  13. Sette, A. & Rappuoli, R. Immunity 33, 530–541 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Burton, D.R., Poignard, P., Stanfield, R.L. & Wilson, I.A. Science 337, 183–186 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Correia, B.E. et al. Nature 507, 201–206 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Haynes, B.F., Kelsoe, G., Harrison, S.C. & Kepler, T.B. Nat. Biotechnol. 30, 423–433 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Kwong, P.D., Mascola, J.R. & Nabel, G.J. Nat. Rev. Immunol. 13, 693–701 (2013).

    Article  CAS  PubMed  Google Scholar 

  18. McLellan, J.S. et al. Science 342, 592–598 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Geall, A.J. et al. Proc. Natl. Acad. Sci. USA 109, 14604–14609 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Hansen, S.G. et al. Nature 473, 523–527 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Parks, C.L., Picker, L.J. & King, C.R. Curr Opin HIV AIDS 8, 401–410 (2013).

    Article  CAS  Google Scholar 

  22. Reinhold, B., Keskin, D.B. & Reinherz, E.L. Anal. Chem. 82, 9090–9099 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Querec, T.D. et al. Nat. Immunol. 10, 116–125 (2009).

    Article  CAS  PubMed  Google Scholar 

  24. Ravindran, R. et al. Science 343, 313–317 (2014).

    Article  CAS  PubMed  Google Scholar 

  25. Li, S. et al. Nat. Immunol. 15, 195–204 (2014).

    Article  PubMed  Google Scholar 

  26. Corti, D. & Lanzavecchia, A. Annu. Rev. Immunol. 31, 705–742 (2013).

    CAS  PubMed  Google Scholar 

  27. Liao, H.X. et al. Nature 496, 469–476 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Wu, X. et al. Science 333, 1593–1602 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Newell, E.W., Sigal, N., Bendall, S.C., Nolan, G.P. & Davis, M.M. Immunity 36, 142–152 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank the Human Vaccines Project Working Group, which included Alan Aderem (Seattle Biomed), Rafi Ahmed (Emory Vaccine Center), Deborah Bae (Robert Wood Johnson Foundation), Ripley Ballou (GlaxoSmithKline), Maharaj K. Bhan (India Department of Biotechnology), Ashley Birkett (PATH Malaria Vaccine Initiative), Dennis Burton (The Scripps Research Institute), Danny Casimiro (Merck), Shane Crotty (La Jolla Institute of Allergy and Immunology), James Crowe (Vanderbilt University School of Medicine), Mark Davis (Stanford University School of Medicine), Hansi Dean (International AIDS Vaccine Initiative (IAVI)), Nathalie Garcon (GlaxoSmithKline), Ann Ginsberg (Aeras), Hana Golding (FDA), Rajat Goyal (IAVI), Barney Graham (National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center), Sanjay Gurunathan (Sanofi), Ian Gust (University of Melbourne), Barton F. Haynes (Duke Human Vaccine Institute, Duke University), Carole Heilman (Federal Liaison, NIAID), Adrian Hill (The Jenner Institute), Wayne Koff (IAVI), Antonio Lanzavecchia (Institute for Research in Biomedicine), John Mascola (NIAID Vaccine Research Center), Julie McElrath (Fred Hutchinson Cancer Research Center), Douglas Nixon (George Washington University), Stanley Plotkin (Vaxconsult), Bali Pulendran (Emory Vaccine Center), Ellis Reinherz (Dana Farber Cancer Institute, Harvard University), Bill Schief (IAVI Neutralizing Antibody Center at The Scripps Research Institute), Robert Seder (NIAID Vaccine Research Center), Mark Slifka (Oregon Health and Science University) and Chris Wilson (Bill & Melinda Gates Foundation); H. Dean, O. Shmaidenko and T. Schenkelberg for coordinating summary reports from group discussions in the workshop; L. Gieber for accessing 'pre-read' materials for the workshop; and S. Glass for logistics and organizational support for the workshop. Support for the Human Vaccines Project workshop was provided by a grant to IAVI (W.C.K.) from the Robert Wood Johnson Foundation.

Author information

Authors and Affiliations

  1. Wayne C. Koff is with the International AIDS Vaccine Initiative, New York, New York, USA.,

    Wayne C Koff

  2. Ian D. Gust is in the Department of Microbiology and Immunology, University of Melbourne, Parkville, Australia.,

    Ian D Gust

  3. Stanley A. Plotkin is with the University of Pennsylvania, Philadelphia, Pennsylvania, USA, and Vaxconsult, Doylestown, Pennsylvania, USA.,

    Stanley A Plotkin

Authors
  1. Wayne C Koff
    View author publications

    Search author on:PubMed Google Scholar

  2. Ian D Gust
    View author publications

    Search author on:PubMed Google Scholar

  3. Stanley A Plotkin
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Wayne C Koff.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Koff, W., Gust, I. & Plotkin, S. Toward a Human Vaccines Project. Nat Immunol 15, 589–592 (2014). https://doi.org/10.1038/ni.2871

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/ni.2871

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing